A review of new science, in plain language

Science Advances  ·  14 August 2026  ·  From issue 23

Mito-TEMPO improves survival rates in npc1 -knockout zebrafish by reducing oxidative stress and enhancing mitophagy via Sod2

In zebrafish, a mitochondria-protecting drug raised survival and eased liver damage from a rare genetic disease.

Wenhao Zhao, Xudong Hu et al.

A rare disease called Niemann-Pick type C harms the liver and brain in young patients. Few treatments exist to help them live longer. In zebrafish bred to lack a key gene tied to this disease, a drug called Mito-TEMPO helped fish survive longer. The drug protects tiny cell power stations from damage. It worked by boosting a protective protein and helping cells clear out damaged parts.

Integrity screen: passed (3 checks) Checked 19 August 2026. Read the source

The plain-language reading of this paper is in the full issue, for subscribers.

Read the full issue

Five vetted papers in plain language, free, every two days

Five papers free every issue, about 15 emails a month. No spam. Leave in one click.

Also in issue 23 15 papers
More from Science Advances